These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35461070)

  • 1. The novel mechanism of Med12-mediated drug resistance in a TGFBR2-independent manner.
    Han Y; Dong Q; Liu T; Chen X; Yu C; Zhang Y
    Biochem Biophys Res Commun; 2022 Jun; 610():1-7. PubMed ID: 35461070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MED12 activates the TGFβ pathway to promote chemoresistance and replication fork stability in BRCA-deficient cells.
    Jackson LM; Dhoonmoon A; Hale A; Dennis KA; Schleicher EM; Nicolae CM; Moldovan GL
    Nucleic Acids Res; 2021 Dec; 49(22):12855-12869. PubMed ID: 34871431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics.
    Zhang S; O'Regan R; Xu W
    Cancer; 2020 Mar; 126(5):939-948. PubMed ID: 31869450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.
    Huang S; Hölzel M; Knijnenburg T; Schlicker A; Roepman P; McDermott U; Garnett M; Grernrum W; Sun C; Prahallad A; Groenendijk FH; Mittempergher L; Nijkamp W; Neefjes J; Salazar R; Ten Dijke P; Uramoto H; Tanaka F; Beijersbergen RL; Wessels LF; Bernards R
    Cell; 2012 Nov; 151(5):937-50. PubMed ID: 23178117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEAT1 repression by MED12 creates chemosensitivity in p53 wild-type breast cancer cells.
    Zhang S; Kim EJ; Huang J; Liu P; Donahue K; Wang Q; Wang Y; Mcilwain S; Xie L; Chen X; Li L; Xu W
    FEBS J; 2024 May; 291(9):1909-1924. PubMed ID: 38380720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-SMAD-miR-520e axis regulates NSCLC metastasis through a TGFBR2-mediated negative-feedback loop.
    Kucuksayan H; Akgun S; Ozes ON; Alikanoglu AS; Yildiz M; Dal E; Akca H
    Carcinogenesis; 2019 Jul; 40(5):695-705. PubMed ID: 30475986
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Siraj AK; Masoodi T; Bu R; Pratheeshkumar P; Al-Sanea N; Ashari LH; Abduljabbar A; Alhomoud S; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
    Gut; 2018 Apr; 67(4):663-671. PubMed ID: 28183795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/β-Catenin Signaling Pathway.
    Al-Hendy A; Laknaur A; Diamond MP; Ismail N; Boyer TG; Halder SK
    Endocrinology; 2017 Mar; 158(3):592-603. PubMed ID: 27967206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs.
    Wang L; Zeng H; Wang Q; Zhao Z; Boyer TG; Bian X; Xu W
    Sci Adv; 2015 Oct; 1(9):e1500463. PubMed ID: 26601288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFBR2‑dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells.
    Fricke F; Mussack V; Buschmann D; Hausser I; Pfaffl MW; Kopitz J; Gebert J
    Int J Oncol; 2019 Oct; 55(4):925-937. PubMed ID: 31432155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR.
    Luo XL; Deng CC; Su XD; Wang F; Chen Z; Wu XP; Liang SB; Liu JH; Fu LW
    Cancer Res; 2018 Jul; 78(13):3532-3543. PubMed ID: 29735544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance.
    Gao H; Bai P; Xiao L; Shen M; Yu Q; Lei Y; Huang W; Lin X; Zheng X; Wei T; Jiang Y; Ye F; Bu H
    J Biol Chem; 2020 Jul; 295(31):10726-10740. PubMed ID: 32532820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MED12 exerts an emerging role in actin-mediated cytokinesis via LIMK2/cofilin pathway in NSCLC.
    Xu M; Wang F; Li G; Wang X; Fang X; Jin H; Chen Z; Zhang J; Fu L
    Mol Cancer; 2019 May; 18(1):93. PubMed ID: 31072327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer.
    Qu Y; Zhang H; Duan J; Liu R; Deng T; Bai M; Huang D; Li H; Ning T; Zhang L; Wang X; Ge S; Zhou L; Zhong B; Ying G; Ba Y
    Oncotarget; 2016 May; 7(22):33286-96. PubMed ID: 27120811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2.
    Zhu X; Zhang T; Zhang Y; Chen H; Shen J; Jin X; Wei J; Zhang E; Xiao M; Fan Y; Mao R; Zhou G
    Cell Signal; 2020 Feb; 66():109470. PubMed ID: 31730895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
    Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
    Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
    Wang J; Liang S; Duan X
    J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer.
    Bai M; Wang P; Yang J; Zuo M; Ba Y
    J Physiol Biochem; 2020 Nov; 76(4):549-560. PubMed ID: 32737704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
    Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
    J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.